Expand Document | Expand Chapter | Full TOC | Printable HTML version
Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages) View the PDF document
Table of Contents
View the documentExecutive Summary
View the documentOverview of activities by the World Health Organization - Dr Lembit Rägo
View the documentOverview of activities by the Nordic Council on Medicines - Dr Ola Westbye
Open this folder and view contentsCountry Experiences
View the documentThe Danish Consumer Council - Ms Margrethe Nielsen
View the documentSwedish Industry Association - Dr Håkan Mandahl
View the documentIntroduction to discussion points - Dr Lembit Rägo
View the documentQuality aspects - Dr Ola Westbye
View the documentPilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
View the documentThe WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
View the documentConcluding discussion
Open this folder and view contentsAnnexes
View the documentReferences
View the documentBack cover
 

Back cover

The Internet is a rapidly expanding, invaluable information and communication resource. But with increasing numbers of patients and health professionals looking for medical information on the Internet, the dangers of biased information and unlawful sale of pharmaceuticals are growing fast. Many National Drug Regulatory Authorities (DRAs) are seeking to counter such problems by providing access to unbiased, good-quality drug information on their web sites.

This report of the Joint Workshop features the WHO Model Web Site for DRAs wishing to create or improve an existing web site, and a fruitful exchange of ideas that identified the minimum information an effective DRA web site should contain.

Pharmaceuticals and the Internet represents just one aspect of WHO’s contribution to drug quality assurance and safety. The three pillars of WHO’s work in this area are: developing internationally recognized norms and standards; establishing and maintaining effective drug regulation; and information support for pharmaceutical regulation.

NLN ISBN 91 8 643256 7
WHO ISBN 92 4 159006 8

to previous section
 

Last updated: April 24, 2012